In vivo multi-parametric imaging of metastatic and non-metastatic breast cancer by Rasul, Raisa B
University of Arkansas, Fayetteville
ScholarWorks@UARK
Biomedical Engineering Undergraduate Honors
Theses Biomedical Engineering
5-2017
In vivo multi-parametric imaging of metastatic and
non-metastatic breast cancer
Raisa B. Rasul
University of Arkansas
Follow this and additional works at: http://scholarworks.uark.edu/bmeguht
Part of the Bioimaging and Biomedical Optics Commons
This Thesis is brought to you for free and open access by the Biomedical Engineering at ScholarWorks@UARK. It has been accepted for inclusion in
Biomedical Engineering Undergraduate Honors Theses by an authorized administrator of ScholarWorks@UARK. For more information, please
contact scholar@uark.edu, ccmiddle@uark.edu.
Recommended Citation
Rasul, Raisa B., "In vivo multi-parametric imaging of metastatic and non-metastatic breast cancer" (2017). Biomedical Engineering
Undergraduate Honors Theses. 48.
http://scholarworks.uark.edu/bmeguht/48
1 
 
In vivo multi-parametric imaging of metastatic and non-metastatic breast cancer 
Raisa Rasul 
Abstract 
A current issue in cancer therapy is the characterization of metastatic tumors, 
which can increase ease of treatment and patient trials. We present an in vivo 
study of metastatic (4T1) and non-metastatic (4T1-TWIST KO) breast tumor sister 
cell lines to understand their metabolic behavior, determine differences in two 
modes of imaging (reflection & transmission), and observe effect of breathing 
higher oxygen percentage on vascular hemoglobin oxygen saturation. After 
injection of 10,000 cells into mice dorsal window chambers, the glucose intake 
and hemoglobin oxygen saturation was measured using a fluorescent glucose 
analog (2-NBDG) and hyperspectral trans-illumination imaging from 520-620 nm 
at 10 nm intervals, respectively. The metastatic tumors exhibited increased 
oxygen saturation and decreased glucose metabolism than non-metastatic 
tumors. Reflection mode of imaging was unable to pick intricacies in tumor 
parameters, and increased inhalation of oxygen caused increase in hemoglobin 
oxygen saturation.  
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Introduction 
Approximately 90% of cancer deaths are caused not by primary tumors but the 
metastases that spread from these primary tumors and invade other areas of the 
body1,2. Current methods of treating cancer include surgical resection and adjuvant 
therapy, such as radiation or chemotherapy, to prevent future reoccurrences of the 
disease. Early detection of metastatic or malignant cancer can improve not only patient 
mortality and ease but can also decrease the economics burden of unnecessary cancer 
treatments and working age people who are unable to work. According to the cancer 
plan of 2011 made by the Department of Health of the United Kingdom, many general 
physicians say that access to diagnostic tests that identify cancer or exclude cancers 
earlier is an important issue that they want to be addressed3. Other doctors agree that 
early detection can prevent increased costs that come with subsequent future 
treatment4.  
It is not possible to give the same treatment for metastatic cancer to all cancer 
patients as it can increase costs and require the patient to be hospitalized for a longer 
period. Cancer treatments includes expensive agents, some of which are bevacizumab, 
cetuximab, irinotecan among others5. Over an 8-week course, the cost for only the 
agents can range from $10,000 to $30,0005. Patients will also unnecessarily suffer the 
toxic side-effects of chemo or radiotherapy. Patient’s ease and economic impact 
combined indicate that it’s important to understand and be able diagnose metastatic 
from non-metastatic cancers.  
Breast cancer one of the most common metastatic cancers, especially among 
western women.  Although the mechanism behind cancer metastatic is complex, 
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previous studies have indicated that cancerous cells exhibits increased glucose uptake 
and metabolism compared to non-cancerous cells6,7. The enhanced expression of 
glucose transporters GLUT1 and GLUT3 observed in cancerous cells indicating a 
method of absorbing glucose7. Glucose plays a major role in the cellular respiration 
pathways, glycolysis, where a molecule of glucose is broken down into two molecules of 
pyruvate and a net total of two ATP molecules are formed. When oxygen is present, 
also known as aerobic respiration, the two pyruvate molecules are catabolized further 
through oxidative phosphorylation until an additional net 30 molecules of ATP are 
produced8. The presence is ATP is important especially for performing the cellular work 
involved in the metastasis process where cells have to break away from the 
extracellular matrix and the basement membrane to enter the bloodstream. Despite the 
advantage of more ATP molecules being produced in oxidative phosphorylation, cancer 
cells undergo high glycolytic metabolism and therefore enhanced glucose consumption, 
which can detected through fluorescence imaging. One reason behind the upregulation 
of glycolysis might be due to obtaining an acidic tumor microenvironment, and then 
developing a resistance to the toxicity, a change which allows dominance of phenotypes 
such as cell proliferation and invasion9.  
Another factor of the tumor microenvironment which can be imaged is how 
saturated the hemoglobin molecules of the red blood cells are with oxygen. 
Oxygenation of the tumor microenvironment is key because low oxygen levels, also 
known as hypoxia, can influence therapy resistance or metastasis of cancer cells10,11.  
While there may be many factors controlling the metastatic outcome, one theory is that 
the metabolism of cancer cells can be explained by the hemoglobin oxygen saturation 
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of the tumor microenvironment, because the presence of oxygen general determines 
whether oxidative phosphorylation will take place or not.  
The goal of our study was to compare changes in glucose metabolism and 
hemoglobin oxygen saturation between metastatic and non-metastatic cell lines, 
determine whether a fluorescence microscope can obtain both trans-illumination and 
reflection mode images using the same field of view, and identify the effect inhaling 
more oxygenated air on the hemoglobin oxygen saturation measurement. Utilizing those 
measurements, we want to develop a model for diagnosing metastatic breast cancer 
cell lines from non-metastatic ones. The panel of cell lines in the study include, 4T1, a 
murine breast cancer tumor, and its derivative 4T1-TWIST KO, which is the identical to 
4T1 with the exception of having the TWIST gene deleted. TWIST is one of the genes 
thought to cause metastatic phenotypes in tumors through the process of epithelial to 
mesenchymal transition, therefore, the 4T1 cells with the TWIST gene are metastatic 
while the 4T1-TWIST KO cells without the gene are theoretically non-metastatic.  We 
measured glucose consumption of these cell lines using 2-[N-(7-nitrobenz-2-oxa-1,3-
diaxol-4-yl)amino]-2deoxyglucose (2-NBDG),a fluorescent analog of glucose, that was 
injected intravenous of the mouse tail. The hemoglobin oxygen saturation was 
measured through hyperspectral trans-illumination imaging of tumors in window 
chambers. 
The amount of light absorbed in a mixture is determined by three factors, the 
absorption coefficient of the different components in the mixture, the concentration of 
the components, and the thickness of the sample. This principle is stated by the Beer 
Lambert Law, 𝐴 =  𝜀𝑐𝑙, where A is the percent of light absorbed, 𝜀 is the absorption 
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coefficient, and 𝑙 is the thickness of the sample. If light in shined onto a tumor while it is 
inside a mouse, some major components absorbing the light will be deoxygenated 
hemoglobin, oxygenated hemoglobin, and melanin (the pigment of in skin). Some 
wavelengths of light are better absorbed than others depending on the element that is 
absorbing. Figure 1. below  display how the molar extinction coefficient of oxygenated 
and deoxygenated hemoglobin change as different wavelengths of light are absorbed.  
 
 
 
 
 
 
 
The measurement of the glucose uptake and hemoglobin oxygen saturation 
might help identify changes in tumor microenvironment between metastatic and non-
metastatic cells.  
 
Figure 1. Hb (oxygenated hemoglobin) and HbO2 (deoxygenated hemoglobin) have different molar 
extinction coefficients at varying wavelengths of light12.  
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Methods 
Glucose uptake was measured through reflectance mode fluorescence imaging 
and hemoglobin oxygen saturation was measured using trans-illumination imaging on a 
bright field microscope. To see whether it’s possible to obtain the same field of view for 
metabolism and oxygen saturation images, reflection mode and transmission mode 
images were taken of same field of view and the differences in the optical parameters 
were observed. A small difference would mean that that is possible to obtain 
hemoglobin oxygen saturation images in reflection mode and thus the same field of 
view in one microscope can be used. Finally, to understand the changes in the oxygen 
saturation, the increased oxygenated air was inhaled by the mouse to see whether an 
increase is also observed in the measured vascular oxygen saturation.  
 
Window Chamber Surgery 
 To observe glucose metabolism and vascular oxygen saturation in vivo, cancer 
cells were injected into a mouse and the growing tumor was imaged subsequently. The 
type of surgery to inject the cells is called the dorsal skinfold window chamber and an 
imaged in shown in Figure 2. The strain of mice used was the female BALB/c and to 
prepare for the surgery, the mouse is shaved of its hair and the remaining hair is 
removed from the surgery areas using hair removal cream. During the period of hair 
removal, the mouse is under anesthesia and breathing in isoflurane for a period of 20 
minutes. The mouse is allowed to wake up from the anesthesia before it is injected with 
approximately 100 ul of an anesthetic that consists of a 1:1:4 ratio of ketamine to 
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xylazine to saline solution and allows freedom of movement while the window chamber 
is placed.  
After the mouse goes under, it 
is placed on a heating pad covered 
with a sterile pad, and a surgical 
marker is used to draw points on the 
dorsal skinfold so that they match with 
the placement of the prongs on the 
window chamber. A metal punch is 
used to puncture the skin on the 
marks, and the three prongs of the 
window chamber is pushed through. 
To stabilize the other side of the 
chamber, a counterpart frame with 
corresponding holes is pushed though 
the prongs and the two frames are stabilized using bolts.  
Using a surgical tweezer and scissor that is bent at the tip, the skin inside the 
window chamber with the smaller hole is cut out while making sure not to cut the skin on 
the opposite side. Approximately 10μl of cancer cells in a PBS solution with a 
concentration of 1x106 cells/ml are injected into the fascial membrane of the skin that is 
present after the cut. The tip of a 30 gauge needle is bent before injecting the cells to 
decrease the chance of the needle puncturing the skin on the other side. After injection, 
the area around the cut is filled with saline using a needle, and a glass coverslip is 
Figure 2. Dorsal skinfold window chamber13.  
8 
 
gently placed so that it’s resting on top of the thin layer of saline. A stabilizing ring is 
firmly but moderately pressed on top of the glass coverslip to prevent it from falling out 
and sealing the cut from the outside environment. Putting too much pressure while 
placing the ring can break the coverslip.  
After the mouse has recovered from the anesthesia, it is injected subcutaneously 
with approximately 60μl of Rhimadyl solution, an analgesic. Following signs of activity 
and movement, the mouse is placed back inside its cage. Sterile techniques are 
performed during the procedure and the mouse is housed in a facility that provides 
routine light-dark cycles.  
 
Hyperspectral Hemoglobin Oxygen Saturation Measurement 
 On the second day after surgery, the mouse in imaged for hemoglobin oxygen 
saturation using a trans-illumination bright-field imaging microscope. The mouse is 
placed under anesthesia while it on the microscope stand. A small nose cone and 
tubing is utilized to deliver the anesthetic gas from the chamber to mice. While it is 
under, the mouse is also breathing in 20% oxygenated air. A 3-D printed microscope 
slice, with holes cut out to match the three prongs of the window chamber is inserted 
onto the window chamber and stabilized with a bolt. The mouse is placed on the stand 
such that the glass coverslip in the chamber is facing the side of microscope with the 
camera. A liquid crystal tunable filter (LCTF) is used to filter the light obtained by the 
camera such that only a single wavelength of light is able to reach the camera. The 
tumor area is imaged using 4x magnification from wavelengths of 520nm to 620nm in 
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10nm increments. Exposure times are changed depending on the intensity saturation of 
the images and are noted down for calibration imaging.  
Afterwards, the mouse is removed from microscope stand and anesthesia and 
placed back in its cage. Since exposure times can vary depending on wavelength, day 
of imaging or mice, the images were calibrated by taking background images with no 
mice on the stand at the same exposure times and the corresponding wavelengths. A 
dark image, with the microscope lamp covered is also obtain to factor in the effect of 
background light on the image intensity. Neutral density filters are used to decrease the 
intensity of all the calibration images because, the images will be extremely saturated if 
nothing is blocking the light from going to the camera. A MATLAB code is used to 
process the images, which subtracts the dark and calibration images from the original 
images and compares the intensity of the pixels at different wavelengths using the Beer 
Lambert Law to extrapolate the concentration of oxygenated hemoglobin. Hemoglobin 
oxygen saturation imaging is continued until tumor grows too large.  
Reflection mode images were obtained by placing a lamp near the microscope 
such that the light is coming from the same side as the camera. After trans-illumination 
imaging, the mouse was kept on the stand and the additional lamp was placed, to have 
a constant field of view between the two different modes of imaging. During reflection 
imaging, the shutter of the microscope was closed to prevent the halogen lamp from 
sending transmitted light to the camera. Reflection and transmission images were taken 
at 4x, 10x, and 20x magnifications since most 2 photon microscopes have a single 20x 
objective but hemoglobin oxygen saturation is obtained at the 4x magnification. 
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The effect of increased oxygen inhaled on hemoglobin oxygen saturation was 
observed by the switching the air that was inhaled by the mouse from 20% oxygen to 
100% oxygen. First 20% oxygenated air was attached to the anesthesia chamber and 
images were obtained and afterwards the images from 100% oxygenated air were 
taken.  
 
Glucose Metabolism Measurement 
The glucose metabolism was measured while the tumor size is still small or 
approximately 8mm3. 2-NBDG, a fluorescent analog of glucose is injected intravenous 
of the mouse tail. The molecule is excited at 470 nm and emits at 535 nm. The mercury 
lamp of the fluorescent microscope is turned on approximately 15 minutes before 
imaging, although it is preferable for it to be on at least 30 minutes to allow the lamp to 
reach its maximum intensity. Hemoglobin oxygen saturation images were taken before 
the fluorescence imaging. The microscope was changed to the correct filter and the 
imaging wavelength was set to 525nm.  Exposure time remained constant for the 
duration of the imaging. Once the microscope was set, the mouse was placed on the 
stand like in trans-illumination imaging and the 2-NBDG was injected. Images were 
obtained once every second for the first 10 minutes, once every 1 minute for the next 35 
minutes, and every 5 minutes for the remaining 30 minutes for a total imaging time of 75 
minutes.  
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Results and Discussion 
 
Non-metastatic tumors exhibited decreased hemoglobin oxygen saturation and 
increased glucose uptake  
 Figure 3. presents the representative images of hemoglobin oxygen saturation on 
days 3, 5 and 7. The images show the tortuousness of the vasculature surrounding the 
tumor and the increased hemoglobin oxygen saturation of the arteries (thin vessels) 
compared to the veins (thick vessels). This concept matches literature as arteries carry 
oxygenated blood to the tissue while veins transport deoxygenated blood away from the 
tissue.  
 
 
 
 
 
 
 
 
4T1-
TWIST 
KO 
4T1 
Figure 3. Representative images of hemoglobin oxygen saturation of non-metastatic 
and metastatic tumors on day 5. Last column of images shows trans-illumination 
images at 550 nm wavelength of light. 
Day 3 Day 5 Day 10 Day 10 
500 um 
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Although from the images it seems as though the 4T1-TWIST KO, the metastatic tumor 
grew larger and has greater angiogenesis, the average hemoglobin oxygen saturation 
between all of the mice suggests that the metastatic 4T1 tumors have increased 
hemoglobin oxygen saturation as the tumor grows. 
 
 
 
 
 
 
 
Figure 4. displays the average hemoglobin oxygen saturation between the metastatic 
and non-metastatic tumors. The data suggests that initially the non-metastatic tumors 
have increased hemoglobin oxygen saturation, however, after around day three the 
metastatic tumors have increased oxygen saturation. This information cannot be fully 
confirmed as the sample size was 2 for the non-metastatic tumor, and 4 for the 
metastatic.  
Since previous studies have indicated that some metastatic tumors are hypoxic 
and thus have a low oxygenated tumor microenvironment; therefore, we expected to 
observe decreased hemoglobin oxygen saturation for the metastatic tumors11. However, 
Figure 4. Mean and standard error of hemoglobin 
oxygen saturation on different days post cell 
injection, sample size for TWIST and 4T1 are n=2 
& 4 respectively. After day 3, 4T1 tumors have 
increased saturation, n=6. 
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one reason for the increased oxygen saturation can be that since metastatic tumors 
need to perform more work, they require more ATP. Therefore, they perform oxidative 
phosphorylation, which is a more efficient pathway for producing energy than glycolysis. 
If this theory is correct, decreased glucose consumption should be observed by the 
metastatic tumors.  
Figure 5. displays the changes in glucose uptake over a period of 60 minutes at 15 
minute intervals. The images suggest that glucose consumption is high initially and then 
gradually starts decreases. In addition, the data supports the previous hypothesis that 
the metastatic tumor will have decreased glucose uptake because it performs oxidative 
phosphorylation. However, the sample size for each tumor is only 1, therefore our 
hypothesis cannot be confirmed.  
 
 
 
 
 
 
 
 
200 um 
4T1-
TWIST 
KO 
4T1 
Figure 5. Representative images of 2-NBDG fluorescence of non-metastatic and metastatic tumors 
on day 5 at different time post injection.  
Baseline T=15 min T=30 min 
 
T=60 min 
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 Figure 6 displays a graph of the 2-NBDG fluorescence which indicates that 
initially fluorescence is low. At approximately 13 minutes after injection, the 
fluorescence reaches a peak, which suggests that the vasculature surrounding the 
tumor is saturated with 2-NBDG. After 13 minutes, the fluorescence decreases 
gradually which indicates that glucose is being transported into the tumor. After about 
85 minutes, glucose is cleared from the tumor field of view.   
Overall, preliminary studies suggest that 4t1-TWIST KO tumors had increased glucose 
metabolism and decreased oxygenation than the metastatic 4T1 tumors. The decreased 
need for glucose uptake might be caused by increased oxygenation or more efficient 
catabolism of glucose. One way to confirm that the 4T1 tumors under more oxidative 
Figure 6. Glucose uptake increases for first 10 mins, then decreases; maximum uptake at ~11 mins; 
n=2. 
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Figure 7. Representative hemoglobin oxygen saturation images of 4T1 tumor at varying 
magnifications and reflection/transmission mode of imaging.  The highlighted area indicates the 
location of the tumor.  
R-mode 
T-mode 
4x 10x 20x 
200 um 500 um 100 um 
phosphorylation than 4T1-TWIST KO is to measure the redox ration of the two tumors 
and compare them.  
 
Reflectance imaging shows decreased resolution of tumor vasculature compared with 
transmission imaging at 10x & 20x magnification   
Figure 7. displays reflection and transmission mode images of 4T1 tumor of the 
same field of view and day with different magnifications. The images between the two 
modes seem to be similar. However, within the red circles, groupings of saturated pixels 
are observed in the reflection mode.  
 
 
 
 
 
 
 
 
Figure 8.  Standard error and means of 
parameters such as blood vessel tortuosity, 
mean straight line distance, and branch 
points of tumor microvasculature compared 
between 3 magnifications at different days; 
Sample size for each group is n=2, 2, 1 &1 
respectively.   
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Measurement of the parameters, from Figure 6.,  between the two modes of 
imaging indicate that at 4x magnification, the values of parameters such as tortuosity, 
mean straight line distance and branch points of tumor vasculature is similar and 
standard error also appears to be low. However, the values of parameters differ greatly 
at 10x and 20x magnifications. A small sample size of 2 and 1 for the 4x and 10/20x 
magnifications makes this data inconclusive, so preliminary studies suggest that 
reflection mode might have decreased resolution to transmission mode at higher 
magnifcations.  
Resolution in measuring parameters such as tortuosity, mean straight line 
distance and branch points of tumor vasculature is lost when tumors are imaged at 
reflection mode in higher magnifications than at transmission mode. The decreased 
resolution might be caused by light reflecting of the glass coverslip that is protecting 
thetumor from the outside environment. However, at 4x magnification, reflection mode 
has the better resolution of tortuosity, mean straight line distance, and vasculature 
branchpoints. As the tumor grows bigger the difference in the values between reflection 
and transmission increases. For example, at day 9, the values between reflection and 
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transmission mode are quite similar for all three parameters. The values of the 
parameters between reflection and transmission images, however, are further apart on 
day 15 than on day 9. The sample size of this data is two, therefore, it is inconclusive.  
 
Inhaling 100% O2 increases hemoglobin oxygen saturation 
Figure 9. indicates that when inhaling 100% oxygenated air, the hemoglobin 
oxygen saturation measured has increased compared to inhaling 21% oxygenate air. 
The vessels have increased intensity of oxygen saturation and the microvasculature 
around the tumor also had increased saturation. The bar graph in Figure 10. quantifies 
the hemoglobin oxygen saturation and indicates that oxygen saturation is approximately 
11% on day 4 and 29% on day 8. When 100% oxygenated air in breathed in the 
hemoglobin oxygen saturation by around 10% on both days. This data shows that 
inhaling more oxygen can increase oxygenation of the tumor microvasculature by 
approximately 10%.    
Overall, the hemoglobin oxygen saturation increased when 100% oxygen, rather 
than room air (21% oxygen), was inhaled by the mouse while it was under anesthesia. 
The tumor oxygenation also increased as the 4T1 tumor grew.   
 
 
 
21% O2  
Day 4 Day 8 
500 um 
um 
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Conclusions 
 We initially set out to set out a base for diagnosing metastatic tumors from non-
metastatic tumors. Our hypothesis was that the metastatic 4T1 tumors will exhibit 
Figure 10. Hemoglobin oxygen saturation 
from 21% to 100% oxygen inhalation and 
on different days post cell injection, each 
of size n=1. Hemoglobin oxygen saturation 
increases by a factor of 2 on day 4, and 
0.33 on day 8.   
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increased glucose metabolism and decreased oxygen saturation than the non-
metastatic 4T1-TWIST KO tumors, as indicated by previous studies. For this reason, we 
measured glucose consumption through fluorescence imaging of an analog of glucose 
(2-NBDG) and hemoglobin oxygen saturation through hyperspectral trans-illumination 
imaging of the tumor from 520 to 620nm. The data rejected our hypothesis and 
suggests that metastatic tumors exhibit increased oxygen saturation and decreased 
glucose metabolism than non-metastatic tumors.  Enhanced efficiency in producing ATP 
through oxidative phosphorylation rather than glycolysis could be explain the 
phenomena that observed. However, further studies are required to identify increased 
oxidative phosphorylation of the metastatic tumors.  
 We also wanted to identify whether reflection mode and transmission imaging 
modes can give similar images, as it is important to be able have both modalities on a 
microscope and be able to image the same field of view. The preliminary studies 
indicate that reflection and transmission mode product similar measurements at 4x 
magnification, although with the increased presence of saturated pixels in the reflection 
mode. At 10x and 20x magnifications, reflection mode outputs vary greatly from 
transmission mode, and might not be able to pick up intricacies in tumor 
microvasculature. However, a small sample size makes it difficult to confirm this 
conclusion.  
 Lastly, we wanted to observe the effect of breathing in 100% oxygenated air 
rather than 21% on the measured hemoglobin oxygen saturation. The data follows what 
was expected, because inhaling in 100% O2 increased the hemoglobin oxygen 
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saturation by approximately 10% on day 4 and 8. A greater sample size will further 
support this conclusion.   
 
Future Directions 
Future studies include including repeating the study with a greater sample size to 
conclusively see whether metastatic tumors might perform more oxidative 
phosphorylation than non-metastatic tumors and ultimately developing a prognosis 
model for metastatic breast tumors.  One method of comparing oxidation 
phosphorylation performance between the two cell lines is to obtain the redox ratio. The 
redox ratio is pixel-wise ratio of flavin adenine dinucleotide (FAD) molecules to 
nicotinamide adenine dinucleotide (NADH) and FAD molecules1. NADH and FAD are 
endogenous fluorophores that are components of the cellular respiration pathway. 
Glycolysis produces 2 NADH and the citric acid cycle produces 6 NADH and FADH2 
molecules. Oxidative phosphorylation uses up the NADH and FAD molecules to make 
ATP.  Thus, a redox ratio close to 1 would indicate more oxidative phosphorylation 
taking place.  Therefore, future studies include fluorescence imaging the NADH and 
FAD of the tumors and also observing how, glucose metabolism, oxidative 
phosphorylation, and hemoglobin oxygen saturation change as the tumor is put through 
hypoxia.  
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